Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
March 21, 2002
Large-scale analysis of the human and mouse transcriptomes
Andrew I Su, Michael P Cooke, Keith A Ching, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 8, 2020
First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20<sup>+</sup> Non-Hodgkin Lymphomas
Ajay K Gopal, Ronald Levy, Roch Houot, et al.
Nature Genetics
|
February 6, 2007
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome
Nathaniel D Heintzman, Rhona K Stuart, Gary Hon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 24, 2013
Initial clinical sensitivity and acquired resistance to MET inhibition in MET-mutated papillary renal cell carcinoma
Jennifer R Diamond, Ravi Salgia, Marileila Varella-Garcia, et al.
Molecular Cancer Therapeutics
|
January 7, 2012
An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735
Kenneth E Hook, Scott J Garza, Maruja E Lira, et al.
Nature Medicine
|
December 11, 2021
Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial
Thomas Powles, Srikala S Sridhar, Yohann Loriot, et al.
Molecular Cancer Therapeutics
|
October 11, 2013
Molecular predictors of sensitivity to the insulin-like growth factor 1 receptor inhibitor Figitumumab (CP-751,871)
Adam Pavlicek, Maruja E Lira, Nathan V Lee, et al.
Cell Research
|
August 31, 2011
Dynamic chromatin states in human ES cells reveal potential regulatory sequences and genes involved in pluripotency
R David Hawkins, Gary C Hon, Chuhu Yang, et al.
Cancers
|
July 29, 2025
Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100
Thomas Powles, Srikala S Sridhar, Joaquim Bellmunt, et al.
Nature
|
March 20, 2009
Histone modifications at human enhancers reflect global cell-type-specific gene expression
Nathaniel D Heintzman, Gary C Hon, R David Hawkins, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Proceedings of the National Academy of Sciences of the United States of America
|
March 21, 2002
Large-scale analysis of the human and mouse transcriptomes
Andrew I Su, Michael P Cooke, Keith A Ching, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 8, 2020
First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20<sup>+</sup> Non-Hodgkin Lymphomas
Ajay K Gopal, Ronald Levy, Roch Houot, et al.
Nature Genetics
|
February 6, 2007
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome
Nathaniel D Heintzman, Rhona K Stuart, Gary Hon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 24, 2013
Initial clinical sensitivity and acquired resistance to MET inhibition in MET-mutated papillary renal cell carcinoma
Jennifer R Diamond, Ravi Salgia, Marileila Varella-Garcia, et al.
Molecular Cancer Therapeutics
|
January 7, 2012
An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735
Kenneth E Hook, Scott J Garza, Maruja E Lira, et al.
Nature Medicine
|
December 11, 2021
Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial
Thomas Powles, Srikala S Sridhar, Yohann Loriot, et al.
Molecular Cancer Therapeutics
|
October 11, 2013
Molecular predictors of sensitivity to the insulin-like growth factor 1 receptor inhibitor Figitumumab (CP-751,871)
Adam Pavlicek, Maruja E Lira, Nathan V Lee, et al.
Cell Research
|
August 31, 2011
Dynamic chromatin states in human ES cells reveal potential regulatory sequences and genes involved in pluripotency
R David Hawkins, Gary C Hon, Chuhu Yang, et al.
Cancers
|
July 29, 2025
Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100
Thomas Powles, Srikala S Sridhar, Joaquim Bellmunt, et al.
Nature
|
March 20, 2009
Histone modifications at human enhancers reflect global cell-type-specific gene expression
Nathaniel D Heintzman, Gary C Hon, R David Hawkins, et al.
Page
of 3